维普期刊资源整合服务平台（V6.5）

536篇 您的检索式：作者名="Khuri"

选中清除导出查看参考文献查看引证文献引用追踪共27页首页上一页第1页下一页末页 /27 跳转

	题名	作者	年代	出处	被引量
1	Targeted therapies in metastatic esophageal cancer: Advances over the past decade显示文摘	Amr Mohamed Bassel El-Rayes Fadlo R. Khuri Nabil F. Saba	2014	Critical Reviews in Oncology / Hematology2014，，：	2
2	Loss of FHIT is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers显示文摘	Tseng JF Kemp BL Khuri FR	1999	Cancer Res1999，59，：	1
3	The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer 显示文摘	Steuer CE Khuri FR Ramalingam SS	2015	Carmer2015，121，8：	1
4	Docetaxel and radiation as combined - modali - ty therapy 显示文摘	Kim ES Khuri FR	2002	Oncology ( Williston Park)2002，16，66：	1
5	Cycloxygenase-2 overexpression is a marker of poor prognosis in stage Ⅰ non-small cell lung cancer 显示文摘	Khuri FR Wu H Lee JJ	2001	Clin Cancer Res2001，7，4：	1
6	Phase II study of paclitaxel,ifosfamide,and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma显示文摘	Shin DM Khuri FR Glisson BS	2001	Cancer2001，91，7：	1
7	Lung cancer:New biological insights and recent therapeutic advances显示文摘	Ramalingam SS Owonikoko TK Khuri FR	2011	CA Cancer J Clin2011，61，2：	1
8	Docetaxel and radiation as combinedmodality therapy 显示文摘	Kim ES Khuri FR	2002	Ontology ( Williston Park )2002，16，66：	1
9	Docetaxel and radiation as combined - modality therapy 显示文摘	Kim ES Khuri FR	2002	Ontology (Hunting/)2002，16，：	1
10	Response surface methodology: 1966-1988显示文摘	Myers R H Khuri A I Carter W H	1989	Technometries1989，31，13：	1
11	Cupins:The Most Functionally Diverse Protein Superfamily显示文摘	Dunwell J M Purvis A Khuri S	2004	Phytochemistry2004，65，：	1
12	Cyclooxygenase-2 overexpression is a marker of poor progression in stage I non-small cell lung cancer显示文摘	KHURI F R WU H LEE J J	2001	Clin Cancer Res2001，7，4：	1
13	Overexpression of cyclin Blin early-stage non-small cell lung cancer and its clinical implication 显示文摘	Sorfia JC Jang SJ Khuri FR	2000	Cancer Res2000，60，15：	1
14	Loss of Fhit Is Frequent in Stage I Non-Small Cell Lung Cancer and in the Lungs of Chronic Smokers显示文摘	Tseng J E Kemp B L Khuri F R	1999	Cancer Res1999，59，：	1
15	A controled trial of intratumoral ONYX-015,a selectively replicating adenovirus,in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer显示文摘	Khuri FR Nemunaitis J Khuri F	2000	Nature Med2000，6，8：	1
16	Minimal sufficient statistics for the unbalanced two-fold nested model显示文摘	Khuri A I Ghosh M	1990	Statistics and Probability Letters1990，10，：	1
17	The Impact of Operative Complexity on Patient Risk Factors显示文摘	Aust J B Henderson W Khuri S	2005	Ann Surg2005，241，6：	1
18	Hypermethylation of the kinase promoter and aggressive ness in stage I non smallcell lung cancer显示文摘	Tang X Khuri F R Lee J J death-associated protein (DAP)	2000	J Natl Cancer Inst2000，92，18：	1
19	Selective replication and oncolysis in p53 mutant tumors with ONYX-015,an E1B-55kD genedeleted adenovirus,in patients with advanced head and neck cancer:a phase Ⅱ trial显示文摘	Nemunaitis J Ganly I Khuri F	2000	Cancer Res2000，1560，22：	1
20	Minimal sufficient statistics for a general class of mixed models显示文摘	Khuri A I	1997	Statistics and Probability Letters1997，35，：	1

返回顶部每页显示：

共27页首页上一页第1页下一页末页 /27 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示